April 26, 2021
April 26, 2021 —
A multi-institutional team of researchers, led by UC San Diego School of Medicine and Moores Cancer Center, has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.
November 24, 2021
November 24, 2021 —
The California Institute for Regenerative Medicine (CIRM) approved a $4.1 million grant to enable University of California San Diego School of Medicine researchers to advance a new chimeric antigen receptor (CAR) T-cell therapy from the laboratory into the clinic.
September 16, 2016
September 16, 2016 —
In a Perspective piece published this week in PNAS, cancer researchers from across the country, including faculty at University of California San Diego School of Medicine and Moores Cancer Center, write that a greater emphasis on immune-based prevention should be central to new efforts like the federal Cancer Moonshot program,…
February 23, 2016
February 23, 2016 —
…to test the safety and efficacy of a novel cellular-immunotherapy that uses modified T cells – one of the immune system’s primary weapons – to treat three different types of blood cancer that often defy existing therapies.
March 7, 2017
March 7, 2017 —
Honjo received the 2016 Kyoto Prize—Japan’s highest private award for global achievement—in the area of “Basic Sciences” for his contributions to medical science. His work has been described as initiating a historic turning point—a “penicillin moment”—in the fight against cancer.
March 26, 2014
March 26, 2014 —
Napoleone Ferrara, MD, distinguished professor of pathology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today among eight recipients of the Canada Gairdner Awards at a ceremony in Toronto.
February 5, 2019
February 5, 2019 —
To make it easier for patients to receive world-class cancer care, UC San Diego Health has added a new multidisciplinary cancer clinic in Hillcrest and expanded its infusion center for both oncology patients and others in need of infusion services.
September 14, 2021
September 14, 2021 —
Using a virus that grows in black-eyed pea plants, researchers developed a new therapy that could keep metastatic cancers from spreading to the lungs, as well as treat established tumors in the lungs.
May 15, 2012
May 15, 2012 —
Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center have identified a new biomarker and therapeutic target for pancreatic cancer, an often-fatal disease for which there is currently no reliable method for early detection or therapeutic intervention.
February 19, 2020
February 19, 2020 —
UC San Diego bioengineers developed a control system that could make CAR T-cell therapy safer and more powerful when treating cancer. By programming CAR T cells to switch on when exposed to blue light, the researchers controlled the cells to destroy skin tumors in mice without harming healthy tissue